February 3, 2025 — Rockville, Md. — Psomagen is thrilled to announce the arrival of Olink® Reveal in our labs. This new panel from Olink Proteomics offers discovery-level proteomics at an affordable price.
The panel targets over 1,000 proteins for a broad view of the proteome. This list includes:
-
537 inflammation or immune response proteins
-
Over 850 disease-associated proteins
-
Over 700 proteins associated with a quantitative trait locus (pQTL)
The panel covers 100% of top-level proteome pathways, and 96% of immune response pathways for a deep look into inflammation. Olink Reveal is designed to work with existing NGS workflows and sample prep. This platform is lowering the cost of entry to proteomics research, especially for pilot projects.
As a long-time user of Olink Proteomics technologies, Psomagen is thrilled to see the new Reveal panel democratize discovery proteomics. Psomagen is an Olink Certified Service Provider for all Olink products. This will include the new Olink Reveal, as well as Explore HT, Flex, Focus, and Target.
About Psomagen
Psomagen, Inc., formerly Macrogen Corp, is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the clinical and academic markets. With both CLIA-certified and CAP-accredited facilities, their team delivers only the highest-quality integrative multi-omics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.
Psomagen Contact
Lori Mull
Spatial Biology & Proteomics Product Manager
lori.mull@psomagen.com
About Olink Proteomics
Olink® Proteomics, now a part of Thermo Fisher Scientific, is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink® Proteomics provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st-century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America, and Asia. Olink® Proteomics is headquartered in Uppsala, Sweden.
